Via Surgical’s soft tissue fixation system was voted as the Top 10 Surgical Solution by MedTech Outlook Review.
Via Surgical Receives FDA Clearance for Its FasTouch™ Absorbable Fixation System
March 18, 2019
LEARN MORE
Via Surgical Ltd, a leading developer of surgical fixation solutions, today announced U.S. Food and Drug Administration 510(k) clearance of the FasTouch™ Absorbable Fixation System.
Via Surgical Ltd. Announces the Appointment of Morris E. Franklin Jr., M.D., F.A.C.S. as Medical Advisor
March 15, 2016
LEARN MORE
Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today that it has appointed Morris E. Franklin Jr., M.D., F.A.C.S. as Medical Advisor.
Via Surgical Ltd., Closes $6M Investment Led by Benslie Investment Group
February 6, 2016
LEARN MORE
Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today the company has secured a $6M investment led by Benslie investment group.
Via Surgical to Exhibit at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan, Italy
April 24, 2015
LEARN MORE
Via Surgical Ltd., a leading developer of a deployable suture mesh fixation system for hernia repair, announced today it will introduce its lead product, FasTouch™, at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan, Italy, from April 25 to 29, 2015.
Via Surgical Ltd. Receives FDA Clearance to Commercialize FasTouch
April 4, 2014
LEARN MORE
Via Surgical Ltd., a leading developer of hernia mesh fixation technologies, today announced that it has received FDA 510(k) clearance to commercialize FasTouchTM
Contact to learn more about Fastouch
If you are interested in FasTouch and would like to receive additional information, please complete the form below, and we will get back to you as soon as possible.
